Search for Clinical Trial Results
Rhabdomyosarcoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Proton RT for the Treatment of Pediatric Rhabdomyosarcoma Condition: Rhabdomyosarcoma Date: 2007-12-28 Interventions: Radiation: Proton Beam Radiation Once per day, 5 days a week for a total of 4 to 6 weeks. |
Recruiting |
Study Name: Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy Condition: Rhabdomyosarcoma Date: 2013-05-30 Interventions:
|
Recruiting |
Study Name: Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory or Relapsed Rhabdomyosarcoma : International Randomized Trial Condition: RHABDOMYOSARCOMA Date: 2011-05-16 Interventions:
|
Recruiting |
Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condition:
|
Completed |
Study Name: Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma Condition:
|
Active, not recruiting |
Study Name: A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping Condition:
Date: 2015-07-24 Interventions:
|
Active, not recruiting |
Study Name: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Condition:
|
Terminated |
Study Name: Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood Condition:
Date: 2005-09-09 Interventions: Drug: Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide |
Completed |
Study Name: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma Condition:
|